氧化应激是PM2.5诱导的肺损伤的枢纽
Tianhua Hou1, Laiyu Zhu2, Yusheng Wang3
1Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, Jilin, 130001, China.
概括
细颗粒物 (PM2.5) 导致氧化应激,导致肺损伤和恶化COPD和喘等呼吸道疾病. 抗氧化剂疗法在保护这些有害影响方面表现有前途.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 肺部病理学 肺部病理学
背景情况:
- 细颗粒物 (PM2.5) 是一个主要的空气污染物,对全球健康有重大影响.
- 由于其作为对吸入污染物的主要防御作用,呼吸系统对PM2.5暴露非常脆弱.
- 暴露于PM2.5与一系列疾病有关,包括心血管,呼吸道,代谢和神经系统疾病.
研究的目的:
- 阐明PM2.5诱导呼吸系统中氧化应激的机制.
- 解释氧化应激在恶化COPD,喘,肺纤维化和癌症等肺部疾病中的作用.
- 审查和提出有效的抗氧化疗法,以减轻PM2.5引起的肺损伤.
主要方法:
- 对PM2.5影响的实验和临床研究的文献综述.
- 对PM2.5诱导的氧化应激所涉及的生化途径的分析.
- 收集关于抗氧化剂治疗疗法的疗效数据.
主要成果:
- PM2.5通过生化反应,酶激活和线粒体功能障碍引发氧化应激.
- 氧化应激激活炎症和细胞损伤路径,恶化肺部状况.
- 抗氧化疗法在预防和治疗PM2.5引起的肺损伤方面已经证明有效.
结论:
- PM2.5对呼吸系统健康构成重大威胁,主要是通过诱导氧化应激.
- 了解这些机制对于制定有针对性的干预措施至关重要.
- 抗氧化剂策略提供了一种可行的方法来对抗PM2.5对肺部的有害影响.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Peroxisomes
12.9K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.9K
Acute Respiratory Failure-II
239
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
239


